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Abstract
With the expansion of the potential applications of carbon nanotubes (CNT) in biomedical fields, the toxicity and
biocompatibility of CNT have become issues of growing concern. Since the immune system often mediates tissue damage
during pathogenesis, it is important to explore whether CNT can trigger cytotoxicity through affecting the immune
functions. In the current study, we evaluated the influence of CNT on the cytotoxicity mediated by human lymphocytes in
vitro. The results showed that while CNT at low concentrations (0.001 to 0.1 mg/ml) did not cause obvious cell death or
apoptosis directly, it enhanced lymphocyte-mediated cytotoxicity against multiple human cell lines. In addition, CNT
increased the secretion of IFN-c and TNF-a by the lymphocytes. CNT also upregulated the NF-kB expression in lymphocytes,
and the blockage of the NF-kB pathway reduced the lymphocyte-mediated cytotoxicity triggered by CNT. These results
suggest that CNT at lower concentrations may prospectively initiate an indirect cytotoxicity through affecting the function
of lymphocytes.
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Introduction
Carbon nanotubes (CNTs) have been shown to have potential
applications in multiple biomedical fields[1,2,3,4,5,6,7,8,9,10], espe-
cially as effective transporters for delivery of various bioactive
molecules such as peptides[11], proteins[12,13,14], DNAs[15,16,17],
RNAs[18], or drugs[19,20]. Our previous study revealed that CNT
conjugated tumor protein could enhance the uptake of tumor antigen
by human dendritic cell (DC) and the capability of DC to induce
anticancer response in vitro. The results suggest that CNT-based
nanotechnology may have a prospec t i v er o l ei nt h ed e v e l o p m e n to f
more efficacious DC-based anticancer immunotherapy.[21] With the
expansion of the scope of prospective CNT applications, the toxicity of
CNT to mammalian cells becomes an issue of great concern. Some
literatures reported that exposing cells to CNT led to cell death[22,23],
apoptosis[24], or inhibition of proliferation[25,26], while others
showed that CNT at lower concentrations had minimal toxici-
ty[27,28,29]and did not significantly affect the function and viability of
cells[27]. So far however, most studies on CNT toxicity have focused
on the changes in cells following direct CNT exposure. The indirect
toxicity mediated by the immune modulation effects of CNT has not
been well explored. Because the immune system often plays a major
role in tissue damage during pathogenesis[30], in addition to studying
the direct CNT toxicity on cells, it is also important to evaluate
whether CNT can trigger cytotoxicity through affecting the function of
lymphocytes. Here in this study, the effects of CNT on lymphocyte-
mediated cytotoxicity on multiple human cell lines were assessed in
vitro. Moreover, we evaluated whether CNT would influence the
proliferation of lymphocytes, the production of IFN-c and TNF-a by
lymphocyte, and the activation of NF-kBi na na t t e m p tt oe x p l o r et h e
mechanisms of the prospective CNT-induced immune cytotoxicity.
Results
1. Characterization of CNT
Functionalized CNT used in this study was prepared using a
method similar to that described in our prior report[31]. Briefly, an
oxidation/sonication procedure was utilized to introduce carboxyl
groups to CNT surface for solubilization enhancement. The
characterization of the functionalized CNT was carried out with
standard methodology[32,33]. Scanning electronic microscopy
revealed that the tube-like structure of CNT was well maintained,
with an average length of 500–800 nm and an average diameter of
20–30 nm. X-ray photoelectron spectroscopy analysis detected
carboxyl groups on the surface of CNT. The resultant CNT
solution had a concentration of 0.2 mg/ml (data not shown, the
results have been describled in the paper we published before).[31]
2. CNT promoted lymphocyte-mediated cytotoxicity
The in vitro cytotoxiciy mediated by the lymphocytes were
measured using a standard methodology that had been employed
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concentration of CNT, various concentrations of CNT (from
0.001 to 1 mg/ml) were tested, with the H23 cell line as the target
cells and the effector to target cell raito (E: T ratio) of 10:1. After
incubation with various concentrations of CNT, the lymphocytes
(effector cells) were thoroughly washed, and co-incubated with the
target cells for 3 more days. The percentage of viable target cells
was then evaluated with an MTS assay[34,35]. The results showed
that the effective working concentration of CNT was between 0.01
to 0.1 mg/ml, with the growth inhibition rates of 53.8466.77%
and 51.5365.17%, respectively (Fig.1A, p,0.05, compare to
control group). The control group used lymphocytes that had not
been exposed to CNT, and generated a growth inhibition rate of
33.41611.44%. The CNT groups of 1 mg/ml and 0.001 mg/ml
did not enhance the growth inhibition to a statistically significant
level compared to the control.
To confirm the immune modulatory effect of CNT, we next
tested whether CNT of 0.01 mg/ml would also induce a
lymphocyte-mediated cytotoxicity against other human cell lines,
across a wider range of E: T ratios (from 40:1 to 5:1). As shown in
Fig 1, CNT of 0.01 mg/ml induced cell growth inhibition
consistently across various human cell lines, including three tumor
cell lines (MCF7, H838 and H23) and two non-tumor cell lines
(HSF and L02). When the MCF7 was used as the target cells, the
CNT induced growth inhibitions were 51.23610.72%,
45.08612.58%, 42.65611.3% and 40.73620.26%, for E/T
ratios of 40:1, 20:1, 10:1 and 5:1, respectively (p,0.05, compared
to control); whereas the control group generated much lower
inhibitions of 28.1566.42%, 20.165.63%, 17.6666.21% and
8.0869.01% respectively. Similar trends were observed in
experiments with other cell lines (Fig 1), suggesting that a low
concentration of CNT could indeed enhance the lymphocyte-
mediated cytotoxicity in vitro.
3. CNT did not influence cell Viability
It is important to investigate whether a prospective CNT
toxicity on the target cells was responsible for the higher tumor
inhibition observed in Fig. 1. To address this issue, the target cells
were incubated for 3 days in either normal medium or mediums
containing CNT of 0.01 or 0.1 mg/ml. The viability of the MCF7
cells was then evaluated by the MTS assay. The results showed no
significant difference in the number of live cells among the groups
(Fig 2A) further explore the issue, we also tested whether CNT of
0.01 mg/ml would induce an apoptosis effect in L02 and HSF cell
lines. As shown in Fig 2B, C CNT failed to induce an obvious
apoptosis in either cell lines at this concentration. These results
suggested that the direct cytotoxicity of CNT was not the major
mechanism of the enhanced growth inhibition observed in Fig 1.
4. Influence of CNTs on lymphocyte proliferation
To explore the mechanism by which CNT enhanced lympho-
cytes’ cytotoxicity, we next evaluated the influence of CNT on
lymphocyte proliferation. CNT of various concentrations (0.001,
0.01, and 0.1 mm/ml) were added to the culture medium, and
lymphocyte proliferation was subsequently evaluated with the
standard technique of [3 H]-thymidine uptake. The results showed
no significant difference among the groups, though CNT of
0.01 mm/ml tended to raise the uptake of [3 H]-thymidine.
(Fig 3A) Moreover, there was no difference in the percentage of
lymphocytes that stayed in G0/G1 phases (Fig 3B).
We also investigated whether CNT would promote the
apoptosis of the lymphocytes. As shown in Fig 4, CNT did not
induce an obvious apoptosis in lymphocytes either. These results
showed that CNT did not significantly affect the lymphocytes
proliferation or apoptosis, suggesting that the enhanced lympho-
cyte-mediated cytotoxicity was probably mediated through other
mechanisms.
We next evaluated if CNT would affect the secretion of
proinflammatory cytokines IFN-c and TNF-a, which are generally
regarded as the key signs of lymphocyte activation. Lymphocytes
were cultured in medium containing CNT of either 0.001, 0.01, or
0.1 mg/ml for 24 hours. The levels of secreted proinflammatory
cytokines IFN-c and TNF-a were measured in culture superna-
tants using a standard double-sandwich ELISA protocol. As
presented in Fig 5, lymphocyte cultured with CNT of 0.01 mg/ml
or 0.1 mg/ml produced significant higher amounts of both
cytokines compared with the untreated cells (p,0.05). The results
suggested that CNT at proper concentrations might promote
lymphocyte activation and the secretion of proinflammatory
cytokines.
5. CNT promote lymphocyte cytotoxicity by NF-kB
To further explore the mechanism of CNT induced lymphocyte
activation, we evaluated the influence of CNT on the NF-kB
pathway in lymphocyte, which is a major transcription factor that
regulates genes responsible for both the innate and adaptive
immune responses. Lymphocytes were incubated in either normal
medium or that contains CNT of 0.01 mg/ml. Nuclear protein was
extracted and the western blotting was utilized to compare the NF-
kB activation in the two groups of lymphocytes. The results
showed that the NF-kB was more activated in the CNT-treated
group (Fig. 6A), Lamin B was used as a control. To further explore
the role of NF-kB activation in CNT induced cytotoxicity, the
effects of NF-kB inhibitor PDTC was evaluated during cytotox-
icity experiments. As presented in Fig 6B, while CNT enhanced
the cytotoxicity against MCF7 cells by the lymphocytes, PDTC
decreased the toxic effect significantly (p,0.05 compared to the
CNT group). These results suggested that the activation of NF-kB
probably involved in the lymphocyte-mediated toxicity induced by
CNT exposure.
Discussion
The toxicity and biocompatibility of CNT have become issues
of great concern with the growth of prospective applications of
CNT in biomedical fields. The aim of this study was to evaluate
the influence of CNT on lymphocyte-mediated cytotoxicity in vitro,
since the immune system often mediates tissue damage during
pathogenesis. The results showed that CNT at low concentration
(0.001 to 0.1 mg/ml) enhanced the immune-mediated cytotoxicity
against multiple types of human cells in vitro (Fig 1), but did not
cause obvious cell death or apoptosis directly (Fig 2). In addition,
CNT increased the secretion of cytokines signaling the activation
of lymphocytes, including -c and TNF-a (Fig 5), but failed to
trigger a proliferation of the lymphocytes (Fig 4). Furthermore,
CNT upregulated the NF-kB expression in immune cells, and the
blockage of the NF-kB pathway reduced the CNT-induced
cytotoxicity by lymphocytes (Fig 6). These results suggest that
CNT at lower concentrations may trigger changes in lymphocytes,
which in turn may cause an indirect cytotoxicity.
Dumorter et al reported that CNTs could be uptaken by
lymphocytes and macrophages in vitro without affecting the cell
viability, and that CNT did not influence the functional activity of
the immune cells[27]. They also noticed that CNT provoked the
secretion of proinflammatory cytokines by macrophages. In
agreement with their findings, the results of this study showed
that CNT could enhance the secretion of IFN-c and TNF-a by
lymphocytes/PBMC. In addition, we observed that CNT also
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human cell lines in vitro. The enhanced cytokine secretion by the
lymphocytes could be partially responsible for the enhanced
immune cytotoxicity induced by CNT, since IFN-c and TNF-a
both mediate inflammatory reactions.
NF-kB is a major transcription factor that regulates genes
responsible for both the innate and adaptive immune response,
including those involved in lymphocyte development, maturation
and proliferation. It has been reported that CNT could activate
the NF-kB pathways in a few types non-immune cells, including
keratinocytes[25], mesothelial cells[22], and lung cancer A549
cells[23]. However, it was unknown whether CNT could also
activate the NF-kB pathway in lymphocytes. Here we observed for
the first time that CNT could upregulate NF-kB expression in
lymphocytes, and that blocking NF-kB reduced the CNT-induced
immune cytotoxicity. The findings suggested that NF-kB was
Figure 1. CNT promoted lymphocyte-mediated cytotoxicity. (A) Percentage of lived H23 cells was killed by Lymphocyte alone or co-
incubation with CNT of various concentrations (n = 6, 6 SD). The star indicates a statistically significant difference between this group and the
Lymphocyte alone groups (p,0.05). (B–F) Percentage of other cell lines (B: H23; C: H838; D: MCF7; E: HSF; F: L02) were killed by Lymphocyte alone or
co-incubation with 0.01 mg/ml CNT on difference E: T ratios (n = 6, 6 SD). The star indicates a statistically significant difference between this group
and the Lymphocyte alone groups (p,0.05).
doi:10.1371/journal.pone.0021073.g001
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cytotoxicity. However, it should be noted that cellular pathways
other than NF-kB could not be excluded, and further studies are
necessary to completely understand the transcriptional mechanism
of the effects triggered by CNT.
The in vivo biological properties of CNT have also been
evaluated in animal models in recent years. While CNT
administered via the respiratory tract can cause severe lung
damages[36,37,38], CNT given intravenously did not affect the
long-term survival of the mice[39,40,41]. Prior research on the
cellular toxicity of CNT mainly focused on the apoptosis or death
of target cells following direct CNT exposure in vitro, while the
indirect CNT toxicity mediated by the immune cells has not been
reported in literature. Here we observed that CNT at low
concentration (0.01 to 0.1 mg/ml) enhanced the lymphocyte-
mediated cytotoxicity against multiple human cell lines in vitro
(Fig 2), but failed to cause obvious cell death or apoptosis directly.
Although this effect needs further evaluation with in vivo studies,
the finding suggested yet another potential mechanism for CNT
induced-toxicity.
In summary, while low-dose CNT failed to induce apoptosis in
target cells directly, they can enhance the lymphocyte-mediated
cytotoxicity in vitro. The results suggest that CNT may potentially
trigger an indirect cytotoxicity through enhancing the function of
lymphocytes.
Materials and Methods
1. Preparation and Characterization of Functionalized
CNT
Multiwalled carbon nanotubes were purchased from Chengdu
Organic Chemicals Co. Ltd., with the purity of greater than 95%,
diameter of 20 to 30 nm, average length of 50 mm, amorphous
carbon of less than 3%, ash (catalyst residue) of less than 1.5%,
special surface area of greater than 233 m
2/g, and the thermal
conductivity of about 2000 W/m
.k. Stable aqueous suspensions of
purified and shortened CNT were prepared by oxidation and
Figure 2. Influence of CNT on cell Viability. (A) Percentage of
different cell lines after co-incubation with CNT of various concentra-
tions (n = 6, 6 SD). (B, C) Effect of CNT on L02 cell apoptosis. The test
was conducted by Annexin-V and PI double staining and analyzed by
flow cytometry. Apoptosis of L02 cells was analyzed in L02 cells alone
(L02), CNT co-cultured with L02 (L02+CNT), Annexin V + means the cells
were PI negative and Annexin V positive. Data are shown as means 6
SD of three independent experiments.
doi:10.1371/journal.pone.0021073.g002
Figure 3. Influence of CNT on lymphocyte proliferation. (A)
Influence of CNT on lymphocyte proliferation, lymphocytes were
cultured alone or co-cultured with CNT of various concentrations for
3 days. [3 H]-thymidine were added at the last 18 hour. (B) Influence of
CNT on cell cycle of lymphocyte. Lymphocytes were cultured alone or
co-cultured with CNT for 3 days, then the cell were collected and
detected by PI.
doi:10.1371/journal.pone.0021073.g003
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described in our previous study[31]. In brief, CNT were
suspended in a 3:1 mixture of concentrated H2SO4/HNO3 and
sonicated at 540 W for 45 s. The resulting mixture was filtered
through a polycarbonate filter membrane of 2 mm pore (Millipore)
and rinsed thoroughly till neutralized. The obtained CNT were
dried completely and suspended in pure water at the concentration
of 0.3 mg/ml by sonication. Centrifugation (5000 rpm for 30 min)
removed the unreacted components from the solution to afford a
stable suspension of CNT. The size and shape of CNT were
evaluated by scanning electron microscopy. The surface element
chemistry of the oxidized CNT was analyzed by X-ray
photoelectric spectroscopy (XPS, VG Escalab MK II, UK). The
CNT suspension was sonicated again prior to mixing with culture
or reaction mediums for further application.
2. Cell Culturing
The human cell lines NCI-H23 (human lung adenocarcinoma),
NCI-H838 (human lung adenocarcinoma), MCF-7 (human breast
adenocarcinoma), L02(human hepatocyte) and HSF(human skin
fibroblast) ,HepG2(human hepatic carcinoma) were maintained in
RPMI 1640 medium (Gibco Life Technologies) supplemented
with 10% fetal calf serum (FCS; Gibco), 100 U/mL penicillin,
100 mg/mL streptomycin in 5% CO2 and humidified atmosphere
at 37uC. All cell lines were purchased from Cell Resource Center,
IBMS, CAMS/PUMC).
3. Preparation of human peripheral blood mononuclear
cells
Healthy volunteers’ blood were collected as we previously
described.[21] Peripheral blood mononuclear cells (PBMC) were
obtained by Ficoll-Paque density gradient centrifugation. All
donors were required to sign an informed consent form according
to procedures approved by the Ethics Committee at Chinese
Academy of Medical Sciences and Peking Union Medical College.
The PBMC were suspended in RPMI 1640 medium supplement-
ed with 10% (vol/vol) FCS, 2 mM L-glutamine, 0.1 mM
nonessential amino acids (Life Technologies, Grand Island, NY),
1 mM sodium pyruvate, 100 U/mL penicillin, 100 mg/mL
streptomycin, 1% HEPES buffer, and 10 mM 2-mercaptoethanol.
The PBMC, consisting of mainly lymphocytes[35], were used as
effector cells in the cytotoxicity studies.
4. Cytotoxicity Studies
The cytotoxicity experiments were conducted using the
standard methods for ex vivo immune studies[35]. Specifically,
the MTS cell viability assay was utilized to evaluate the condition
of various target cells. MTS assay is a currently well-adopted
method that is superior than the MTT assay in both sensitivity and
applicability[34,35]. The MCF7, H23, H838, HSF and L02 cells
were employed here as the target cells. For various experimental
groups the lymphocytes/PBMC were first incubated for 3 days
Figure 4. Influence of CNT on lymphocyte apoptosis. The test was conducted by Annexin-V and PI double staining and analyzed by flow
cytometry. Apoptosis of lymphocyte cells was analyzed in lymphocyte cells alone (Lymphocyte), CNT co-cultured with lymphocyte
(Lymphocyte+CNT), Annexin V + means the cells were PI negative and Annexin V positive. Data are shown as means 6 SD of five independent
experiments.
doi:10.1371/journal.pone.0021073.g004
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0.1, 0.01 and 0.001 mg/ml of CNT respectively. After 3 days, the
lymphocytes (effector cells) were removed and washed for 4 times
with PBS, before mixing with the target cells for the cytotoxicity
study.
The cytotoxicity study was performed in 96-well U-bottom
plates according to standard protocols [35]. The target cells were
added to the wells with culture medium and incubated for 4 hours
so that the cells became adherent. Effector cells were mixed in the
wells according to the indicated effector:target (E:T) ratios. The
total volume per well was adjusted to 200 ml. The plate was then
incubated in a CO2 incubator at 37uC for 3 days. The positive
control and the background control were set up according to the
instruction of the manufacturer (MTS Cell Titer Kit, Promega)
and each used 6 wells. The background control was taken from 6
wells containing medium and MTS solution. The positive control
was taken from 6 wells containing the target cells, medium and
MTS, but without the effector cells. After 3 days, the supernatants
were removed, and the plates were washed thrice with PBS. One
hundred ml RPMI 1640 and 20 ml MTS solution were added per
well. The plates were incubated for about 90 minutes at 37uC.
When the color turned to brown, the plates were measured for
light absorption by an ELISA plate reader at 490 nm. Each
experiment was repeated in 6 wells to ensure reliable readings.
Results were compared by analysis of variance (ANOVA), using
the SPSS13.0 software. P value of ,0.05 was considered
significant. The percentage cytotoxicity was calculated according
to the following equation (A490 indicates the light absorption at
490 nm)[35]:
% Cytotoxicicty ~ 1
A490 Experimental well  A490 Background
A490 Positive control  A490 Background

|100
5. Cell Viability Assays after CNT Treatment
MCF7, H838, H23, L02, or HSF cells were washed twice with
aseptic PBS, followed by a 10-minute centrifugation at 1000 rpm.
The spun-down cells were re-suspended in RPMI 1640 culture
medium supplemented with 10% FBS. Proper amount of CNT
(0.1 mg or 0.01 mg) was added to 500 ml RPMI and thoroughly
mixed, and incubated with 1610
6 cells at 37uC with 5% CO2 for
72 hours. The viability of the cells was then evaluated by the MTS
method described above.
6. Effects of CNT on cell apoptosis
CNT and human cell lines were prepared as described above.
Human cell lines L02 and HSF were cultured in either normal
medium or that containing CNT (0.01 mg/ml) for 3 days. The cells
were harvested and quantified, stained with Annexin-V kit (BD,
USA), and analyzed with flow cytometry (FACS Vantage).
7. Effects of CNTs on lymphocyte apoptosis
CNT and lymphocytes were prepared as described above.
Lymphocytes were cultured in either normal medium or that
containing CNT (0.01 ug/ml) for 3 days. The cells were harvested
and quantified, stained with Annexin-V kit (BD, USA), and
analyzed with flow cytometry (FACS Vantage).
Figure 5. CNT promote lymphocytes secretion cytokines.
Lymphocyte cell were cultured alone or co-cultured with CNT of
various concentrations for 24 hours. The levels of secreted cytokines
IFN-c and TNF-a were measured in culture supernatants by ELISA.
doi:10.1371/journal.pone.0021073.g005
Figure 6. CNT promote lymphocytes Cytotoxicity by NF-kB. (A)
The influence of CNT on the concentration of NF-kB p65 in the
lymphocyte cell nuclei. Lymphocytes were incubated in either normal
medium or that contains CNT of 0.01 mg/ml for 24 hours. Nuclear
protein was extracted and the western blotting was utilized to compare
the NF-kB activation. Lamin B was used as control. (B) The influence of
NF-kB inhibitor PDTC on the lymphocyte-mediated cytotoxicity of CNT.
MCF7 were co-cultured with Lymphocyte or Lymphocyte added CNT, or
Lymphocyte added CNT and PDTC. The percent of lived MCF7 cell were
detected by MTS.
doi:10.1371/journal.pone.0021073.g006
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The lymphocytes were incubated in RPMI 1640 medium with
10%FBS that contained CNT of 0.1, 0.01, or 0.001 m g/ml for
72 hours. Control wells contained lymphocytes cultured in
medium without CNT. Cultures were pulsed with 1 mCi/well [3
H]-TdR (Shanghai Nucleus Research Institute, China) on day 2,
and harvested 18 hours later with a Tomtec automated harvester
(Wallac Inc.). Thymidine uptake by lymphocytes was quantified
with a liquid scintillation & luminescence counter (Wallac
MicroBetaH TriLux).
9. Effects of CNT on cell cycle phase of lymphocytes
Lymphocytes were cultured alone or co-cultured with CNT for 3
days,thenharvestedandquantified.OnemillionLymphocyteswere
fixed with 70% cold ethanol at 4uC for 60 min, washed with PBS
twice, and stained with 50 mg/ml PI (Sigma) at room temperature
for 5 min. Flow cytometry of the lymphocytes was then performed.
Data were analyzed with ModFIT software
10. Effects of CNT on IFN-c and TNF-a Production
The lymphocytes were incubated in RPMI 1640 medium with
10%FBS that contained CNT of 0.1, 0.01, or 0.001 mg/ml for
72 hours. Control wells contained lymphocytes cultured in medium
without CNT. Culture supernatants were collected. The IFN-c and
TNF-a in the supernatants were measured by standard sandwich
ELISA techniques using the Quantikine Immunoassay Kit (Jingmei
Inc,Shenzhen, China) according to the manufacturer’s instructions.
The plates were measured for light absorption by an ELISA plate
reader (Bio-Rad) with a 450 nm filter.
11. Western blot assay of NF-kB
The lymphocytes were incubated in RPMI 1640 medium with
10%FBS and CNT of 0.01 mg/ml for 24 hours. Control wells
contained lymphocytes cultured in medium without CNT. The
nuclear proteins were extracted using a nuclear protein extraction
kit (Nanjing KeyGen Biotech, China). Standard western blotting
procedures were carried out with specific NF-kB p65 antibody
(Santa Cruz), Lamin B antibody (Santa Cruz), and secondary
antibodies labeled with horseradish peroxidase (Santa Cruz).
Antibody/antigen complexes were detected using the ECL reagent
(Millipore).
12. Inhibition effect of NF-kB by PDTC
To further explore the role of NF-kB activation in CNT
induced cytotoxicity, the effects of NF-kB inhibitor PDTC
(Pyrrolidinedithiocarbamic acid, ammonium salt) was evaluated
during cytotoxicity experiments. As presented in Fig. 6, while
CNT enhanced the cytotoxicity against MCF7 cells by the
lymphocytes, PDTC decreased the toxic effect significantly
(p,0.05 compared to the CNT group). These results suggested
that the activation of NF-kB probably involved in the lymphocyte-
mediated toxicity induced by CNT exposure.
13. Statistics
Statistical analysis was performed with the statistical SPSS 13.0
software. The nonparametric test was used to calculate the
probability of significant differences among the groups. Statistical
significance was defined as p ,0.05.
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